176 related articles for article (PubMed ID: 37892405)
1. Integration with Transcriptomic and Metabolomic Analyses Reveals the
Guo Y; Liu Z; Wu Q; Li Z; Yang J; Xuan H
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892405
[TBL] [Abstract][Full Text] [Related]
2. Bioactive components and mechanisms of poplar propolis in inhibiting proliferation of human hepatocellular carcinoma HepG2 cells.
Liu H; Li J; Yuan W; Hao S; Wang M; Wang F; Xuan H
Biomed Pharmacother; 2021 Dec; 144():112364. PubMed ID: 34700230
[TBL] [Abstract][Full Text] [Related]
3. Chinese Poplar Propolis Inhibits MDA-MB-231 Cell Proliferation in an Inflammatory Microenvironment by Targeting Enzymes of the Glycolytic Pathway.
Li J; Liu H; Liu X; Hao S; Zhang Z; Xuan H
J Immunol Res; 2021; 2021():6641341. PubMed ID: 33628847
[TBL] [Abstract][Full Text] [Related]
4. Global changes to HepG2 cell metabolism in response to galactose treatment.
Skolik RA; Solocinski J; Konkle ME; Chakraborty N; Menze MA
Am J Physiol Cell Physiol; 2021 May; 320(5):C778-C793. PubMed ID: 33439775
[TBL] [Abstract][Full Text] [Related]
5. Oviductus ranae protein hydrolysate (ORPH) inhibits the growth, metastasis and glycolysis of HCC by targeting miR-491-5p/PKM2 axis.
Xu Q; Dou C; Liu X; Yang L; Ni C; Wang J; Guo Y; Yang W; Tong X; Huang D
Biomed Pharmacother; 2018 Nov; 107():1692-1704. PubMed ID: 30257387
[TBL] [Abstract][Full Text] [Related]
6. UP12, a novel ursolic acid derivative with potential for targeting multiple signaling pathways in hepatocellular carcinoma.
Dong H; Yang X; Xie J; Xiang L; Li Y; Ou M; Chi T; Liu Z; Yu S; Gao Y; Chen J; Shao J; Jia L
Biochem Pharmacol; 2015 Jan; 93(2):151-62. PubMed ID: 25522955
[TBL] [Abstract][Full Text] [Related]
7. Mitochondria-targeted antioxidant and glycolysis inhibition: synergistic therapy in hepatocellular carcinoma.
Dilip A; Cheng G; Joseph J; Kunnimalaiyaan S; Kalyanaraman B; Kunnimalaiyaan M; Gamblin TC
Anticancer Drugs; 2013 Oct; 24(9):881-8. PubMed ID: 23872912
[TBL] [Abstract][Full Text] [Related]
8. Shikonin differentially regulates glucose metabolism via PKM2 and HIF1α to overcome apoptosis in a refractory HCC cell line.
Yang W; Liu J; Hou L; Chen Q; Liu Y
Life Sci; 2021 Jan; 265():118796. PubMed ID: 33220292
[TBL] [Abstract][Full Text] [Related]
9. A Multi-Omics Study Revealing the Metabolic Effects of Estrogen in Liver Cancer Cells HepG2.
Shen M; Xu M; Zhong F; Crist MC; Prior AB; Yang K; Allaire DM; Choueiry F; Zhu J; Shi H
Cells; 2021 Feb; 10(2):. PubMed ID: 33672651
[TBL] [Abstract][Full Text] [Related]
10. Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1α-dependent and -independent mechanism.
Wan X; Liu Y; Zhao Y; Sun X; Fan D; Guo L
PLoS One; 2017; 12(9):e0184213. PubMed ID: 28886081
[TBL] [Abstract][Full Text] [Related]
11. Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.
Chen B; Wei W; Ma L; Yang B; Gill RM; Chua MS; Butte AJ; So S
Gastroenterology; 2017 Jun; 152(8):2022-2036. PubMed ID: 28284560
[TBL] [Abstract][Full Text] [Related]
12. Chinese Propolis Suppressed Pancreatic Cancer Panc-1 Cells Proliferation and Migration via Hippo-YAP Pathway.
Tao L; Chen X; Zheng Y; Wu Y; Jiang X; You M; Li S; Hu F
Molecules; 2021 May; 26(9):. PubMed ID: 34068565
[TBL] [Abstract][Full Text] [Related]
13.
Gao L; Wang KX; Zhang NN; Li JQ; Qin XM; Wang XL
J Proteome Res; 2018 May; 17(5):1833-1843. PubMed ID: 29589762
[No Abstract] [Full Text] [Related]
14. A polymeric prodrug of cisplatin based on pullulan for the targeted therapy against hepatocellular carcinoma.
Wang Y; Liu Y; Liu Y; Zhou W; Wang H; Wan G; Sun D; Zhang N; Wang Y
Int J Pharm; 2015 Apr; 483(1-2):89-100. PubMed ID: 25681730
[TBL] [Abstract][Full Text] [Related]
15. SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.
Zhao P; Chen L; Li LH; Wei ZF; Tong B; Jia YG; Kong LY; Xia YF; Dai Y
BMC Cancer; 2014 Dec; 14():987. PubMed ID: 25527123
[TBL] [Abstract][Full Text] [Related]
16. Portuguese propolis disturbs glycolytic metabolism of human colorectal cancer in vitro.
Valença I; Morais-Santos F; Miranda-Gonçalves V; Ferreira AM; Almeida-Aguiar C; Baltazar F
BMC Complement Altern Med; 2013 Jul; 13():184. PubMed ID: 23870175
[TBL] [Abstract][Full Text] [Related]
17. Differential response of hepatocellular carcinoma glycolytic metabolism and oxidative stress markers after exposure to human amniotic membrane proteins.
Alves AP; Rocha SM; Mamede AC; Braga PC; Alves MG; Oliveira PF; Botelho FM; Maia CJ
Mol Biol Rep; 2022 Aug; 49(8):7731-7741. PubMed ID: 35716291
[TBL] [Abstract][Full Text] [Related]
18. TO901317 inhibits the development of hepatocellular carcinoma by LXRα/Glut1 decreasing glycometabolism.
Xiong T; Li Z; Huang X; Lu K; Xie W; Zhou Z; Tu J
Am J Physiol Gastrointest Liver Physiol; 2019 May; 316(5):G598-G607. PubMed ID: 30817182
[TBL] [Abstract][Full Text] [Related]
19. STAT3 regulates glycolysis via targeting hexokinase 2 in hepatocellular carcinoma cells.
Li M; Jin R; Wang W; Zhang T; Sang J; Li N; Han Q; Zhao W; Li C; Liu Z
Oncotarget; 2017 Apr; 8(15):24777-24784. PubMed ID: 28445971
[TBL] [Abstract][Full Text] [Related]
20. Reprograming of Glucose Metabolism by Zerumbone Suppresses Hepatocarcinogenesis.
Wani NA; Zhang B; Teng KY; Barajas JM; Motiwala T; Hu P; Yu L; Brüschweiler R; Ghoshal K; Jacob ST
Mol Cancer Res; 2018 Feb; 16(2):256-268. PubMed ID: 29187559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
